Related Experiment Video
Updated: Apr 19, 2026
08:31
Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions
Published on: December 1, 2020
5.7K
Peptide based diagnostics: are random-sequence peptides more useful than tiling proteome sequences?
Krupa Arun Navalkar1, Stephan Albert Johnston1, Phillip Stafford1
1Center for Innovations in Medicine, The Biodesign Institute at Arizona State University, PO Box 875901, Tempe AZ 85281, USA.
Journal of Immunological Methods
|December 16, 2014
Summary
Random sequence peptides show higher accuracy for diagnosing Valley Fever (Coccidioides infection) than specific epitope peptides. This finding advances the development of next-generation immunodiagnostics.
Area of Science:
- Immunology
- Infectious Diseases
- Diagnostic Development
Background:
- Peptide-based diagnostics have limitations in specificity, hindering widespread adoption.
- Current diagnostics for Coccidioides (Valley Fever) lack high sensitivity and specificity.
Purpose of the Study:
- To evaluate two distinct peptide-based diagnostic approaches for Valley Fever.
- To compare the diagnostic accuracy of epitope-based peptides versus random sequence peptides.
Main Methods:
- Utilized a microarray format to test overlapping Coccidioides epitope peptides.
- Employed a 10,000-peptide immunosignaturing microarray to identify and compare random sequence peptides.
Main Results:
- Random sequence peptides demonstrated superior accuracy in classifying Valley Fever infection stages compared to epitope peptides.
- Epitope peptide arrays outperformed existing immunodiffusion arrays but were less accurate than random sequence peptides.
Conclusions:
- Suggests that random sequence peptides offer higher diagnostic potential for Valley Fever than specific epitope peptides.
- Highlights the complex interplay of antibody recognition, pathogen sequence, and mimotopes in immunodiagnostic development.
